On Friday, Lilly(Eli) & Co (NYSE: LLY) opened lower -2.37% from the last session, before settling in for the closing price of $640.86. Price fluctuations for LLY have ranged from $633.20 to $972.53 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 18.77% annually for the last half of the decade. Company’s average yearly earnings per share was noted 72.20% at the time writing. With a float of $848.74 million, this company’s outstanding shares have now reached $946.83 million.
In an organization with 47000 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 82.87%, operating margin of 42.77%, and the pretax margin is 31.66%.
Lilly(Eli) & Co (LLY) Insider Updates
A key investor’s attitude towards the stock of the Drug Manufacturers – General industry is another important factor to consider. The insider ownership of Lilly(Eli) & Co is 10.32%, while institutional ownership is 73.61%. The most recent insider transaction that took place on Aug 08 ’25, was worth 127,913. In this transaction Director of this company bought 200 shares at a rate of $639.56, taking the stock ownership to the 9,402 shares. Before that another transaction happened on Jul 24 ’25, when Company’s 10% Owner sold 280,000 for $805.07, making the entire transaction worth $225,419,259. This insider now owns 95,736,978 shares in total.
Lilly(Eli) & Co (LLY) Performance Highlights and Predictions
If we go through the results of last quarter, which was made public on 9/30/2024, the company posted 1.18 earnings per share (EPS) for the quarter, coming under the agreed prediction (set at 1.47) by -0.29. Wall Street market experts anticipate that the next fiscal year will bring earnings of 6.91 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 72.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 42.40% during the next five years compared to 18.77% growth over the previous five years of trading.
Lilly(Eli) & Co (NYSE: LLY) Trading Performance Indicators
Check out the current performance indicators for Lilly(Eli) & Co (LLY). In the past quarter, the stock posted a quick ratio of 1.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 11.12. Likewise, its price to free cash flow for the trailing twelve months is 121.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 15.08, a number that is poised to hit 6.24 in the next quarter and is forecasted to reach 30.14 in one year’s time.
Technical Analysis of Lilly(Eli) & Co (LLY)
Let’s dig in a bit further. During the last 5-days, its volume was 10.39 million. That was better than the volume of 4.03 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 6.06%.
During the past 100 days, Lilly(Eli) & Co’s (LLY) raw stochastic average was set at 0.67%, which indicates a significant decrease from 0.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 22.25 in the past 14 days, which was lower than the 23.82 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $772.12, while its 200-day Moving Average is $799.34.
